This company seems to have been delisted
Reason: Merged with Sun Pharma
Last recorded trade on: August 23, 2024
Source: https://www.prnewswire.com/news-releases/sun-pharma-completes-taro-merger-302180230.html
Reason: Merged with Sun Pharma
Last recorded trade on: August 23, 2024
Source: https://www.prnewswire.com/news-releases/sun-pharma-completes-taro-merger-302180230.html
Taro Pharmaceutical
TARO
40,01 €
Share price
0.00%
Change (1 day)
9.16%
Change (1 year)
Categories
Taro Pharmaceutical (TARO) - Total assets
Total assets on the balance sheet as of December 2023 : €2.01 Billion
According to Taro Pharmaceutical's latest financial reports the company's total assets are €2.01 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Taro Pharmaceutical - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-03-31 | €1.95 B | 0.44% |
| 2022-03-31 | €1.94 B | -5.03% |
| 2021-03-31 | €2.05 B | -3.28% |
| 2020-03-31 | €2.12 B | 11.64% |
| 2019-03-31 | €1.90 B | -3.66% |
| 2018-03-31 | €1.97 B | -7.9% |
| 2017-03-31 | €2.14 B | 10.99% |
| 2016-03-31 | €1.93 B | 20.31% |
| 2015-03-31 | €1.60 B | 71.8% |
| 2014-03-31 | €0.93 B | 8.22% |
| 2013-03-31 | €0.86 B | |
| 2011-12-31 | €0.61 B | 46.49% |
| 2010-12-31 | €0.41 B | 4.07% |
| 2009-12-31 | €0.40 B | 18.78% |
| 2008-12-31 | €0.33 B | 2.23% |
| 2007-12-31 | €0.33 B | 2.85% |
| 2006-12-31 | €0.32 B | -30.45% |
| 2005-12-31 | €0.46 B | -9.91% |
| 2004-12-31 | €0.51 B | 4.9% |
| 2003-12-31 | €0.48 B | 34.77% |
| 2002-12-31 | €0.36 B | 4.27% |
| 2001-12-31 | €0.34 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 | €198.67 B | 9,764.92% | 🇺🇸 USA |
 | €109.02 B | 5,313.60% | 🇺🇸 USA |
 | €167.67 B | 8,225.89% | 🇺🇸 USA |
 | €36.61 B | 1,717.97% | 🇮🇱 Israel |
 | €69.47 B | 3,349.58% | 🇬🇧 UK |
 | €95.19 B | 4,626.65% | 🇨🇭 Switzerland |